Bannerbild German Brest Group - Studien

PALLAS (GBG87)

PALLAS: PALbociclib CoLlaborative Adjuvant Study

Sponsor: AFT (USA), ABCSG (Non-USA)
A cooperation of BIG, GBG, NSABP, PrECOG

 
 

Introduction

Einführungstext eingeben

News

Trial is recruiting.

Design

A randomized phase III trial of Palbociclib with adjuvant endocrine therapy versus endocrine therapy alone for hormone receptor positive (HR+)/ human epidermal growth factor receptor 2 (HER2)-negative early breast cancer

Documents

Participating sites  can access internal documents at the Pallas portal.

Available trial documents:

No entries available

Contact

pallas@gbg.de
Fax: +496102 / 7480-440

Projektmanagement
Dr. Cornelia Schneider-Schranz

GBG Forschungs GmbH
Martin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440

+49 6102 7480-0 | nfGBGd